Global Ophthalmic Handheld Devices Market Size To Exceed USD 0.61 Billion By 2033 | CAGR of 2.21%
May 16, 2024 22:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 16, 2024 (GLOBE NEWSWIRE) -- The Global Ophthalmic Handheld Devices Market Size is to Grow from USD 0.49 Billion in 2023 to USD 0.61 Billion by 2033, at a Compound...
Cell and Gene Therapy Manufacturing Research Report 2024
May 15, 2024 09:07 ET
|
Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
May 15, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new...
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
May 15, 2024 06:30 ET
|
Ocugen
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Iridex Reports First Quarter 2024 Financial Results
May 14, 2024 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Global Neurotrophic Keratitis Market Report 2024, with Profiles of Dompe, Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Oculis and HLB Therapeutics
May 14, 2024 08:57 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.The global neurotrophic keratitis...
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting
May 14, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
PDAT clinical outcomes for infectious keratitis from Brazil and Mexico KNOXVILLE, TN, May 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB:...
Sulfur Hexafluoride (SF6) Global Strategic Industry Report 2024-2024 - Growth of Gas-Insulated Switchgear Market to Drive Opportunities for SF6
May 14, 2024 05:58 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Sulfur Hexafluoride (SF6) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Sulfur Hexafluoride...
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 21:50 ET
|
Belite Bio, Inc
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related...
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
May 13, 2024 08:00 ET
|
Annexon Biosciences
Multiple Value-creating Catalysts Across the Annexon Portfolio Throughout 2024 Pivotal Phase 3 Data for ANX005 in Guillain-Barré Syndrome (GBS) Expected in Second Quarter 2024; Potential to be the...